Sean Harper Insider Profile
4 Followers
Sean Harper, EVP, Research & Development at Amgen, holds 56.08K shares in Amgen (Ticker: AMGN).
Sean Harper's Trading History
| AMGNAmgen | Jul 16, 2018 | EVP, Research & Development | Uninformative Sell | 298.46K | $25.93M | |
AMGN Insider Shares: 56.08K (<0.01%) | ||||||
You May Also Like
Sean Harper insider profile FAQ
What is the percentage of profitable transactions made by Sean Harper?
The percentage of profitable transactions made by Sean Harper is 50%.
What is the average return per transaction made by Sean Harper?
The average return per transaction made by Sean Harper is -19.10%.
What stocks does Sean Harper hold?
Sean Harper holds: AMGN stocks.
What was Sean Harper’s latest transaction?
Sean Harper’s latest transaction was an Uninformative Sell of $298.46K.
What was Sean Harper's most profitable transaction?
Sean Harper’s most profitable transaction was an Informative Sell of AMGN stock on April 22, 2015. The return on the trade was 1.30%.
What is Sean Harper's role in Amgen?
Sean Harper's role in Amgen is EVP, Research & Development.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
